18.01.07 Transcription mRNA processing and translation Flashcards
Where does transcription occur?
In the nucleus.
What is the function of mRNA, how is it synthesised?
RNA polymerase II - carries genetic information
What is the function on tRNA and how is it synthesised?
RNA polymerase III - Mediates decoding of mRNA sequence in conjunction with the ribosome.
What is the function of rRNA and how is it synthesised?
Formation of large and small ribosome subunits. Synthesises by RNA polymerase I, with the exception of the 5S subunit synthesised by RNA polymerase III
What is the function of the snRNAs (7SK, 7SM), how are they synthesised.
7SK - processing of pre-mRNA regulating transcription by controlling the positive transcription elongation factor P-TEFb
7SM - (7-2 or RNase MRP) - In mitochondria it plats a direct role in the initiation of mitochondrial DNA replication. In the nucleus it is involved in precursor rRNA processing.
RNA polymerase II (some III)
What is the function of the scRNAs (7SL), how is it synthesised.
RNA polymerase III (some II)
7SL - component of the signal recognition particle (SRP). SRP directs protein trafficking in the cell.
How is transcription initiated?
TF bind to the promoter region and position RNA polymerase to initiate RNA syntheses.
Describe the structure of the promoter.
Promoters are cis-acting i.e. function limited to duplex on which they reside. They contain:
1) TATA box - 25bp - 35 bp from TSS defines direction of transcription.
2) GC box - ~110bp upstream from TSS. functions in either orientation.
3) CAAT box ~80bp upstream of TSS. Strongest determination of promoter efficiency. Functions in either orientation.
What is the effect of a mutation in the TATA box?
Does not prevent initiation of transcription but causes transcription to begin at an incorrect location.
What are the possible effects of mutations in the promoter region?
1% of single base pair substitutions caysing genetic disease occur in promoter region
Disrupt transcrtipional initation altering the amount of mRNA and protein.
Alter or abolish binding capacity of cis-acting DNA sequence motifs for trans-acting TFs.
Give two examples of disease caused by mutations in transcriptional regulatory element.
- B-thalassemia
- FH
- Pyruvate kinase deficiency
- Haemophilia B
Describe enhancers.
1) cis-acting short sequence elements
2) enhance transcriptional activity
3) variable distance from start site
4) function independent of orientation
5) bind gene regulatory proteins causing DNA between promotor and enhancer to loop out and proteins bound to enhancer to interact with promoter bound TFs or RNA polymerase
Describe silencers.
1) Similar properties to enhancers
2) Inhibit transcriptional activity.
What are the stages of post-transcription RNA processing?
1) splicing
2) 5’ capping
3) Polyadenylation
When does 5’ capping occur and what is its purpose?
Occurs during elongation
Methylated nucleoside, 7-methylguanosine (m7G) is linked to the 5’ end of the RNA via a 5’-5’ phosphodiester bond
Possible functions:
1) Protect from 5’3’ exonuclease activity
2) Facilitate transport from the nucleus to the cytoplasm
3) Facilitate RNA splicing
4) Role in attachment of the 40S subunit of the cytoplasmic ribosomes to the mRNA